| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022492 |
| Receipt No. | R000025915 |
| Official scientific title of the study | Observation of changes in ocular structural and functional parameters before and after steep Trendelenburg positioning during robotic-assisted laparoscopic radical prostatectomy (RALP) |
| Date of disclosure of the study information | 2016/12/01 |
| Last modified on | 2016/05/27 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Observation of changes in ocular structural and functional parameters before and after steep Trendelenburg positioning during robotic-assisted laparoscopic radical prostatectomy (RALP) | |
| Title of the study (Brief title) | Ocular parameter change after RALP | |
| Region |
|
|
| Condition | ||
| Condition | prostatic cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To measure perioperative intraocular pressure. To compare the thicknesses of the peripapillary retinal nerve fibre layer (RNFL), ganglion cell complex (GCC), and central foveal (CF) before and after RALP. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The thicknesses of the peripapillary RNFL, GCC, and CF measured with spectral domain optical coherence tomography. Humphrey perimetry was performed before, and 3 and 6 months after surgery. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Patients with prostatic cancer | |||
| Key exclusion criteria | Patients were excluded if they had pre-existing glaucoma and retinal vascular diseases that may affect neuroretinal function or corneal diseases that may affect the IOP measurement. | |||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Masahiro Zako |
| Organization | Aichi Medical University |
| Division name | Department of Ophthalmology |
| Address | 1-1 Karimata, Yazako, Nagakute, Aichi |
| TEL | 0561623311 |
| Mzako@aol.com | |
| Public contact | |
| Name of contact person | Masahiro Zako |
| Organization | Aichi Medical University |
| Division name | Department of Ophthalmology |
| Address | 1-1 Karimata, Yazako, Nagakute, Aichi |
| TEL | 0561623311 |
| Homepage URL | http://www.aichi-med-u.ac.jp/su06/su0611/su061100/__icsFiles/afieldfile/2013/05/29/rin_H25-02.pdf |
| Mzako@aol.com | |
| Sponsor | |
| Institute | Department of Ophthalmology
Aichi Medical University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 愛知医科大学病院(愛知県)/Aichi Medical University Hospital (Aichi Prefecture) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | The mean visual acuity (logarithm of the minimal angle of resolution), IOP, mean deviation, and pattern standard deviation measured by the Humphrey field analyser showed no statistically significant difference before and after surgery. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025915 |